The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology
Open accessAbstract
This white paper discusses prospects for advancing hyperpolarization technology to better understand cancer metabolism, identify current obstacles to HP (hyperpolarized) 13 C magnetic resonance imaging’s (MRI’s) widespread clinical use, and provide recommendations for overcoming them. Since the publication of the first NIH white paper on hyperpolarized 13 C MRI in 2011, preclinical studies involving [1- 13 C]pyruvate as well a number of other 13 C labeled metabolic substrates have demonstrated this technology's capacity to provide unique metabolic information. A dose-ranging study of HP [1- 13 C]pyruvate in patients with prostate cancer established safety and feasibility of this technique. Additional studies are ongoing in prostate, brain, breast, liver, cervical, and ovarian cancer. Technology for generating and delivering hyperpolarized agents has evolved, and new MR data acquisition sequences and improved MRI hardware have been developed. It will be important to continue investigation and development of existing and new probes in animal models. Improved polarization technology, efficient radiofrequency coils, and reliable pulse sequences are all important objectives to enable exploration of the technology in healthy control subjects and patient populations. It will be critical to determine how HP 13 C MRI might fill existing needs in current clinical research and practice, and complement existing metabolic imaging modalities. Financial sponsorship and integration of academia, industry, and government efforts will be important factors in translating the technology for clinical research in oncology. This white paper is intended to provide recommendations with this goal in mind.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Spin-exchange optical pumping of noble-gas nuclei
Walker, T. G., & Happer, W. (1997) · Reviews of Modern Physics · doi:10.1103/revmodphys.69.629 · Cited by 1,444
Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1- 13 C]Pyruvate
Nelson, S. J., Kurhanewicz, J., Vigneron, D. B., Larson, P. E. Z., Harzstark, A. L., Ferrone, M., van Criekinge, M., Chang, J. W., Bok, R., Park, I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006070 · Cited by 1,286
Self-citationParahydrogen and synthesis allow dramatically enhanced nuclear alignment
Bowers, C. R., & Weitekamp, D. P. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00252a049 · Cited by 1,028
Day, S. E., Kettunen, M. I., Gallagher, F. A., Hu, D.-E., Lerche, M., Wolber, J., Golman, K., Ardenkjaer-Larsen, J. H., & Brindle, K. M. (2007) · Nature Medicine · doi:10.1038/nm1650 · Cited by 883
Self-citationMagnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate
Gallagher, F. A., Kettunen, M. I., Day, S. E., Hu, D.-E., Ardenkjær-Larsen, J. H., Zandt, R. I. ‘., Jensen, P. R., Karlsson, M., Golman, K., Lerche, M. H., et al. (2008) · Nature · doi:10.1038/nature07017 · Cited by 849
Self-citationHenry, N. L., & Hayes, D. F. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.01.010 · Cited by 849
Felig, P. (1973) · Metabolism · doi:10.1016/0026-0495(73)90269-2 · Cited by 794
Shankar, L. K., Hoffman, J. M., Bacharach, S. L., Graham, M. M., Karp, J. S., Lammertsma, A. A., Larson, S. M., Mankoff, D. A., Siegel, B. A., den Abbeele, A. V., et al. (2006) · PubMed · Cited by 674
Self-citationProgress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2626 · Cited by 671
Self-citation
Cited by
Crosby, D., Bhatia, S., Brindle, K. M., Coussens, L. M., Dive, C., Emberton, M., Esener, S., Fitzgerald, R. C., Gambhir, S. S., Kuhn, P., et al. (2022) · Science · doi:10.1126/science.aay9040 · Cited by 1,379
Self-citationGranlund, K. L., Tee, S.-S., Vargas, H. A., Lyashchenko, S. K., Reznik, E., Fine, S., Laudone, V., Eastham, J. A., Touijer, K. A., Reuter, V. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.024 · Cited by 138
Self-citationDeuterium metabolic imaging reports on tert expression and early response to therapy in cancer
Batsios, G., Taglang, C., Tran, M., Stevers, N., Barger, C., Gillespie, A. M., Ronen, S. M., Costello, J. F., & Viswanath, P. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4418 · Cited by 40
Self-citationImaging cancer metabolism using magnetic resonance
Brindle, K. M. (2024) · npj Imaging · doi:10.1038/s44303-023-00004-0 · Cited by 22
Self-citation
Metadata
- Authors
- Kurhanewicz, J., Vigneron, D. B., Ardenkjaer-Larsen, J. H., Bankson, J. A., Brindle, K., Cunningham, C. H., Gallagher, F. A., Keshari, K. R., Kjaer, A., Laustsen, C., Mankoff, D. A., Merritt, M. E., Nelson, S. J., Pauly, J. M., Lee, P., Ronen, S., Tyler, D. J., Rajan, S. S., Spielman, D. M., Wald, L., Zhang, X., Malloy, C. R., & Rizi, R.
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 21
- Issue
- 1
- Pages
- 1-16
- ISSN
- 1476-5586 (ISSN-L)
- OpenAlex
- W2901018275
- Cited by
- 440
- References
- 120
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology. https://app.cochat.ai/papers/10.1016/j.neo.2018.09.006
- The paper
- Kurhanewicz, J., Vigneron, D. B., Ardenkjaer-Larsen, J. H., Bankson, J. A., Brindle, K., Cunningham, C. H., Gallagher, F. A., Keshari, K. R., Kjaer, A., Laustsen, C., Mankoff, D. A., Merritt, M. E., Nelson, S. J., Pauly, J. M., Lee, P., Ronen, S., Tyler, D. J., Rajan, S. S., Spielman, D. M., . . . Rizi, R. (2019). Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology. Neoplasia. https://doi.org/10.1016/j.neo.2018.09.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.